preludetx
This role supports the design, initiation, and execution of study protocols while conducting literature research and competitive intelligence for clinical product candidates. The position involves contributing to the development of clinical regulatory documents, collaborating with cross-functional teams on study materials, and analyzing clinical data for internal and external deliverables. It also includes supporting clinical safety meetings, drafting presentations, and acting as a backup contact for medical monitor inquiries.
Headquarters
Wilmington, Delaware, United States
Company Size
51-200 employees
Founded
2016
Prelude Therapeutics is a leading precision oncology company developing innovative medicines for cancer patients with high unmet need. Its pipeline features highly selective KAT6A degraders, mutant-selective JAK2V617F JH2 inhibitors, and next-generation degrader antibody conjugates (DACs) with novel payloads — new approaches to clinically validated targets with transformative potential. Leveraging deep expertise in targeted protein degradation and precision small-molecule design, Prelude's mission is to extend the promise of precision medicine to every cancer patient in need.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for preludetx.
preludetx didn’t post a salary, so this is our estimate from similar listings.